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Mycoplasma hyopneumoniae vaccination at or
shortly before weaning under ﬁeld conditions:
a randomised efﬁcacy trial
I. Arsenakis, A. Michiels, R. Del Pozo Sacristán, F. Boyen, F. Haesebrouck, D. Maes
This study assessed the efﬁcacy of two different Mycoplasma hyopneumoniae vaccination
programmes in relation to the time of weaning. Eight hundred and twenty-eight piglets
were randomly divided into three groups: group V1 was vaccinated three days before
weaning, group V2 at weaning (21 days of age) and group NV was left non-vaccinated.
Vaccinations were performed using Ingelvac MycoFLEX. After the nursery period, 306 pigs
were allocated to fattening unit (F1) and 501 pigs to a second unit (F2). Efﬁcacy was
evaluated using performance parameters and pneumonia lesions at slaughter. Statistically
signiﬁcant differences were obtained in F2 where group V1 had a higher average daily
weight gain compared to groups V2 and NV for the entire study period (17 and 18 g/day,
respectively) and the fattening period (26 and 36 g/day, respectively) (P<0.05). Considering
respiratory disease scores for both fattening units, group V1 was the only group where
coughing severity did not increase signiﬁcantly between placement and the end of the
fattening period (P>0.05). Between groups, there were no statistically signiﬁcant differences
for the average lung lesion scores (V1=3.44; V2=4.61; NV=4.55, P>0.05) and the prevalence
of pneumonia (V1=35.0 per cent; V2=38.0 per cent; NV=41.4 per cent, P>0.05). Overall,
vaccination against M hyopneumoniae before weaning provided numerically better
performance than vaccination at weaning, but did not reach statistical signiﬁcance. An
inﬂuenza outbreak in F1 and the presence of coexisting mixed respiratory infections in both
F1 and F2 could have possibly inﬂuenced the performance of both vaccinated groups across
all measured parameters.
Introduction
Mycoplasma hyopneumoniae is the primary agent of enzootic
pneumonia (EP) which affects mainly grow-ﬁnishing pigs and
inﬂicts major economic losses on the pig industry (Thacker and
Minion 2012). Vaccination is a very common control measure
which has been extensively proven to reduce performance losses,
the severity of clinical signs and lung lesions (Maes and others
1998, 1999, Jensen and others 2002, Wilson and others 2012, Del
Pozo Sacristán and others 2014).
Currently, vaccination at weaning is commonly practised as
the handling of the piglets is inevitable at that time (Alarcon
and others 2014, Del Pozo Sacristán and others 2014). On the
other hand, weaning is one of the most stressful events in the
life of a piglet (Pié and others 2004, Campbell and others 2013).
It is not recommended to vaccinate animals when they are
severely stressed (Chase and others 2012). For that reason, vac-
cinating the animals two to three days before weaning is also
practised by some pig producers (Gillespie and others 2010).
Consequently, one important question that remains unad-
dressed is whether vaccination at the day of weaning has an
inﬂuence on the efﬁcacy of M hyopneumoniae vaccines. A previ-
ous study investigated the efﬁcacy of a single M hyopneumoniae
vaccination three days before weaning or at weaning against
experimental challenge infection with a virulent M hyopneumo-
niae ﬁeld strain (Arsenakis and others 2016). The results
showed that the group that was vaccinated three days before
weaning had the lowest macroscopic and histopathological
lung lesions. A difference of three days between the two vaccin-
ation groups was chosen to allow the ﬁrst and most critical
steps of the immune response to develop before the stress of
weaning (Kick and others 2011). However, signiﬁcant differ-
ences between the vaccinated groups were only obtained for
the histopathological lung lesions. Thus, it was considered that
a ﬁeld study would provide further insight on the same topic,
since it would permit to include more animals, to test the
effect under practical conditions with concurrent infections
with other respiratory pathogens and to investigate perform-
ance data until slaughter age.
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The objective of this study was therefore to investigate the
efﬁcacy of a one-dose M hyopneumoniae vaccination applied
either at weaning or three days before weaning in a Belgian pig
herd with mixed respiratory disease in the fattening period,
where M hyopneumoniae has been involved as an important
pathogen. Average daily weight gain (ADG) and the severity of
Mycoplasma-like pneumonia lesions at slaughter constituted the
primary efﬁcacy parameters.
Materials and methods
Herd description
The study was conducted between September 2013 and March
2014 in a two-site Belgian pig herd, operating a four-week batch
production system for the sows (Table 1). At three weeks of age,
the piglets were weaned and transferred to the nursery unit
located on the same site. The nursery unit consisted of six com-
partments with 20 pens per compartment (20 pigs per pen).
Each compartment had fully slatted ﬂoors, channel ventilation
and a stocking density of 0.27 m2/pig. At 10 weeks of age,
approximately 30 per cent of the pigs were sold, while the
remaining ones were allocated to two different fattening units,
in which they were kept until slaughter (27 weeks of age). The
ﬁrst fattening unit (F1) was within-site and consisted of three
compartments of 26 pens each (13 pigs per pen). The second fat-
tening unit (F2) was located 5 km from the sow herd and con-
sisted of ﬁve compartments of six pens each (13 pigs per pen)
and of two compartments of four pens each (14 pigs per pen).
Both F1 and F2 had fully slatted ﬂoors, conventional mechanical
ventilation systems (combining vent doors and ceiling fans) and
a stocking density of 0.75 m2/pig.
One month before the onset of the study, tracheobronchial
swabs (TBS) were collected from 10-week, 16-week and
24-week-old pigs (10 for each age group) and the results showed
that 7/10, 5/10 and 10/10 pigs, respectively, were positive for
M hyopneumoniae by nested PCR (nPCR; Stärk and others 1998).
Blood samples were obtained from 24-week-old pigs, and 9/10
were serologically positive for M hyopneumoniae (sample to posi-
tive (S/P) values higher than 0.4) using an indirect ELISA
(HerdCheck M hyo, IDEXX). One hundred of those fattening
pigs were examined at the slaughterhouse, and Mycoplasma-like
lung lesions were present on 51 per cent of the lungs. Before the
initiation of the study, the herd did not perform any vaccination
of the fattening pigs, apart from the one against boar taint
(Improvac, Zoetis).
Study population and experimental design
In total, 828 pigs originating from one batch of sows were
selected for this study. These pigs were offspring from 69 ran-
domly selected sows. The parity distribution of the selected
sows was from 1 (n=15) to 13 (n=1), with an average±sd of 2.6
±1.8 parity number. Parity 2 sows constituted the largest group
(n=34). At 14 days of age, the pigs were individually ear-tagged
and randomly allocated to one of the three treatment groups.
Within each litter, an equal number of pigs (n=4) was allocated
to each treatment group (blocked randomisation). This experi-
mental design was followed so that there is no difference
between treatment groups in the average parity number of the
sows providing the piglets. By that way, confounding factors
that might inﬂuence the results could be minimised. All alloca-
tions were performed by the third author. Finally, each treat-
ment group consisted of 276 pigs.
The three treatment groups were: V1 (vaccinated before
weaning at 18 days of age), V2 (vaccinated at the day of
weaning, at 21 days of age, one to three hours before the separ-
ation from the sow) and a non-vaccinated (NV) group. Pigs in
groups V1 and V2 received a single-dose intramuscular injection
(1 ml) of a commercial M hyopneumoniae bacterin vaccine
(Ingelvac MycoFLEX, Boehringer Ingelheim).
In the nursery unit, piglets from maximum three different
litters were regrouped according to weight and sex, while upon
transfer to the fattening units, the pigs from maximum two differ-
ent nursery pens were regrouped according to pen size and sex.
Animals housed within the same pen in the nursery and fattening
units belonged to the same treatment group. Within the nursery
and fattening units, the different treatment groups were allocated
alternately between the pens, until each compartment was full. In
the nursery unit, only two out of the six available compartments
were ﬁlled with animals included in the trial. In F1, only one com-
partment was used, whereas in F2, all compartments were used.
During the entire trial, water and commercial feed (meal) were
supplied ad libitum to the pigs. Feed (commercial meal), housing,
management factors, sex distribution and prophylactic treatment
were the same for the three groups. The study was approved by
the ethical committee for animal experiments of the Faculty of
Veterinary Medicine, Ghent University (EC2013/171).
Parameters of comparison
Performance parameters
In order to obtain the ADG (g/pig/day), all pigs were individu-
ally weighed at two weeks of age, at the end of the nursery
period (10 weeks of age) and before slaughter (27 weeks of age).
Weighing was performed in a blinded manner with respect to
the treatment status by ﬁrst and second authors and animal
caretakers.
Clinical parameters
Coughing severity was measured blindly by the ﬁrst author
every two weeks, starting from the beginning of the fattening
period. All measurements throughout the fattening period were
obtained following the same pen order, each time starting at
8:00, ﬁrst from F1 and then directly moving to F2. The number
of pigs coughing per pen was counted for 10 minutes. Then, a
respiratory disease score (RDS) was calculated by dividing the
number of pigs per pen that coughed during 10 minutes by the
total number of pigs in that pen, multiplied by 100 (Mateusen
and others 2002, Del Pozo Sacristán and others 2012).
In case of respiratory or neurological signs, only treatment
with amoxicillin by intramuscular injection or via the drinking
water was allowed. Possible respiratory disease problems were
monitored by paired sera from 10 coughing pigs, obtained during
the outbreak and three weeks later (referred to as pre-serum and
post-serum samples, respectively). The sera were analysed to
detect antibodies against porcine reproductive and respiratory
syndrome virus (PRRS(V)) (HerdCheck PRRS ELISA, IDEXX),
porcine circovirus type 2 (PCV-2) (IgM and IgG, Ingezim PCV2
TABLE 1: Herd description and health management practices
Number of sows 450
Breed of sows Topigs 20
Breed of boars for artificial
insemination
Piétrain
Vaccination of sows
PRRS(V) Ingelvac PRRS MLV, Boehringer
Atrophic rhinitis Porcilis AR-T, MSD
Escherichia coli Porcilis coli, MSD
Parvovirus+Erysipelothrix
rhusiopathiae
Porcilis Ery-Parvo, MSD
Vaccination of gilts in quarantine unit
PRRS(V) Ingelvac PRRS MLV, Boehringer
Atrophic rhinitis Porcilis AR-T, MSD
E coli Porcilis coli, MSD
Medication in the farrowing unit Iron (Uniferon, Pharmacosmos) at day 5
Toltrazuril orally (Baycox, Bayer) at day 5
Medication in the nursery unit
(days 21–70)
In-feed zinc oxide after weaning for 14 days
at 2500 ppm
Medication in the fattening unit
(days 70–200)
Flubendazole at 10 weeks of age via the feed
(Flubenol 5 per cent premix, Elanco Animal
Health) for five days, repeated every 6 weeks
Gonadotrophin-releasing factor analogue
vaccine (Improvac, Zoetis) against boar taint
at 10 and 18 weeks of age
PRRS(V), porcine reproductive and respiratory syndrome virus.
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ELISA, Ingenasa), swine inﬂuenza virus (SIV) (H1N1, H1N2,
H3N2, standard haemagglutination inhibition test), M hyopneu-
moniae (HerdCheck M hyo, IDEXX), Haemophilus parasuis (Hps
OppA, Biocheck) and Actinobacillus pleuropneumoniae (serotypes
1, 9 or 11 and serotype 2; Swinecheck APP 1,9,11 and
Swinecheck APP 2, Biovet). Additionally, paired nasal swabs
from the same animals were collected to monitor SIV by a real-
time reverse transcription PCR (rRT-PCR; VetMAX-Gold SIV
Detection Kit, Life technologies) detecting type A SIV-speciﬁc
RNA (Bowman and others 2016).
Postmortem examination was performed on a subset of dead
pigs in order to assess the possible cause of death. In all cases,
postmortem examinations were combined with bacteriological
culture, antimicrobial susceptibility testing and histopathology.
Serological examination
Blood samples were collected from the same 20 randomly
selected pigs per group at 2, 10, 18 and 26 weeks of age to
measure antibodies against M hyopneumoniae, using a blocking
ELISA (infectious disease enzyme immunoassay, M hyopneumo-
niae enzyme immunoassay Kit, Oxoid, UK) as previously done
by Del Pozo Sacristán and others (2014). In each treatment
group, equal numbers of sampled pigs were distributed across
fattening units. Inhibition percentages (IP) for all sera were also
calculated considering the optical density (OD) value of each
serum sample as well as the negative control according to Sibila
and others (2004). Classiﬁcation of individual sera on the basis
of IP values was as follows: IP <30 per cent, negative; IP >50
per cent, positive; IP ≥30 per cent and ≤50 per cent, equivocal.
Thirty blood samples (ﬁve for each group/fattening unit)
were randomly selected from the blood samples collected at
26 weeks of age. These were additionally tested for the presence
of antibodies to PRRS(V), PCV-2, SIV, H parasuis and A pleurop-
neumoniae. The serological tests used were the same as the ones
used to investigate respiratory disease diagnostics (see Clinical
parameters section).
Detection of M hyopneumoniae using qPCR on TBS
TBS were collected from 20 pigs per group at 10, 14 and
18 weeks of age (the same 20 pigs from which blood samples
were collected). Sampled pigs were endotracheally intubated
with a sterile, semirigid canine urinary catheter, as described by
Vangroenweghe and others (2015). All samples were immedi-
ately cooled at 4°C and stored at −20°C until analysis. The
material collected by TBS was used to quantify M hyopneumoniae
organisms by quantitative PCR (qPCR) as previously described
by Marois and others (2010) and Del Pozo Sacristán and others
(2012).
Lung lesions
The prevalence of Mycoplasma-like pneumonia lesions, ﬁssures
and pleurisy were recorded at slaughter via a blinded manner
from the second author with the assistance of the ﬁrst author.
The total area (percentage) of macroscopically visible
Mycoplasma-like lung lesions (lung lesion score) was quantiﬁed
according to the scoring system described by Morrison and
others (1985a) and Del Pozo Sacristán and others (2012, 2014).
Mycoplasma-like pneumonia lesions (catarrhal bronchopneumo-
nia (CBPn)) were deﬁned as red-purplish areas of cranioventral
consolidation raised above the surface or at the surface of each
lobe and with a liver-like consistency (Holyoake and Callinan
2006, Del Pozo Sacristán and others 2012, 2014). Chronic
Mycoplasma-like pneumonia lesions (ﬁssures) were grey to purp-
lish cranioventral scars, shrunken below the surface of the lobes,
and had a more solid texture than the unaffected neighbouring
parenchyma (Sorensen and others 2006, Del Pozo Sacristán and
others 2012, 2014). Pleurisy was evident as ﬁbrous adhesions
between the lung lobes and/or the lungs and thoracic wall (Del
Pozo Sacristán and others 2012, 2014, Michiels and others 2015).
Statistical analysis
The number of animals in each treatment group (276) allowed
to assess a difference of 19 g (sd=80) in ADG and 3.2 points
(sd=13) in lung lesion score with 95 per cent certainty and 80
per cent statistical power (Win Episcope 2.0, Edinburgh, UK).
The ADG and lung lesion score were the primary outcome para-
meters. Analysis of variance (ANOVA) was used to analyse body-
weights, ADG and RDS with treatment, compartment and sex
included as ﬁxed factor and pen as a random variable. In the
combined model (including both fattening units), unit was add-
itionally included as a random variable. Pairwise comparisons
between the different treatment groups were made using
Scheffe’s test. Data that did not fulﬁl the criteria of normality
and homogeneity of variances (lung lesion scores, qPCR values
and serology IP) were analysed using non-parametric
Kruskal-Wallis ANOVA. RDS and qPCR (time and group effect)
data were analysed using repeated measures ANOVA. The
average RDS summarised until 20 weeks of age and between 20
and 26 weeks of age were compared within each group using
paired t-tests. Mortality rate, the percentage of pigs showing
Mycoplasma-like lesions, ﬁssures and pleurisy, the percentage of
pigs showing M hyopneumoniae antibodies and the percentage
positive on qPCR were analysed using logistic regression with
treatment and fattening unit as predictors for the model.
Statistical results were considered signiﬁcant when P values were
≤0.05 (two-sided test). The statistical package SPSS V.21.0 was
used to analyse the data.
Results
Performance parameters
No statistically signiﬁcant differences for the average body-
weight were shown between groups at inclusion in the study
(2 weeks of age) (P=0.919), end of the nursery period (10 weeks
of age) (P=0.109) and before slaughter (at 27 weeks of age,
taking into account both fattening units) (P=0.263) (Table 2).
When taking into account each fattening unit separately
(Table 3), signiﬁcant differences between groups for weight gains
and ADG were observed only in F2. More speciﬁcally, group V1
had signiﬁcantly higher weight gains and ADG when compared
with groups V2 and NV.
Clinical parameters
There was a signiﬁcant difference between F1 and F2 in the
overall average RDS (no group effect) between 20 and 26 weeks
of age (P=0.011). Coughing severity increased towards the end
of the fattening period (between 20 and 26 weeks of age)
(Table 4). Taking into account the average of both fattening
units, the paired t-test results revealed signiﬁcant differences
between the two fattening periods in groups NV and V2
(P=0.031 and P=0.007, respectively), but not in group V1
(P=0.194).
During both fattening periods from 10 to 20 and from 20 to
26 weeks of age, higher average RDS were observed in F1 com-
pared with F2 (Table 4). The coughing severity in F1 increased at
approximately 20 weeks of age among all groups (Fig 1). For that
reason, all pigs in F1 were medicated for a ﬁve-day period with
amoxicillin via the drinking water. Paired sera from F1 showed
that 8/10 pigs had a positive post-serum titre (higher than 80)
for the H3N2 subtype of SIV, with an average of 152. All
pre-serum samples had a titre of 20. Moreover, all nasal swabs
(10/10) collected at the same time as the pre-serum were positive
for SIV type A. Serology for M hyopneumoniae showed an average
S/P ratio of 0.81 for the pre-serum (9/10 pigs positive) and an
average S/P ratio of 1.02 for the post-serum (9/10 pigs positive).
Additional serology on pre-serum and post-serum samples
showed that at both collection points 10/10 animals were posi-
tive for PRRS(V). Also, 10/10 pigs and 1/10 pigs were tested
PCV-2 IgG and PCV-2 IgM positive, respectively.
Approximately three weeks after the occurrence of respira-
tory problems in F1, sporadic non-productive coughing was also
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observed in F2, mainly in group NV (Fig 1). A similar ﬁve-day
treatment with amoxicillin via the drinking water was used. The
serological test for M hyopneumoniae showed an average S/P ratio
of 0.79 for the pre-serum (7/10 pigs positive) and an average S/P
ratio of 1.08 for the post-serum (9/10 pigs positive). Moreover,
all pre-sera and post-sera were positive for PRRS(V) and
anti-PCV-2 IgG antibodies.
The numbers of dead pigs in different treatment groups are
presented in Table 5. In total, 55 pigs died during the entire
study period. Postmortem examination was performed on a
subset of dead animals (17/55): ﬁve from the nursery and six
each for F1 and F2. All pigs that underwent postmortem examin-
ation and died during the nursery period had pathological signs
of ﬁbrinopurulent pericarditis and endocarditis. Streptococcus suis
was isolated from the heart and kidneys. The pigs that died
during the fattening period showed either pathological signs of
respiratory or/and wasting disease characterised by pleurisy, peri-
carditis and/or purulent peritonitis. Several bacteria were isolated
from the lungs of those pigs: Trueperella pyogenes (7/12),
Pasteurella multocida (4/12) and S suis (6/12). The main pathogen
isolated from the pigs with pericarditis/purulent peritonitis
was S suis.
Serological examination
The serological results for M hyopneumoniae at 2, 10, 18 and
26 weeks of age are presented in Table 6. Regarding the average
IP values from both units, at 10, 18 and 26 weeks of age, the
vaccinated groups V1 and V2 exhibited higher average values
when compared with NV (P=0.004, P=0.066 and P=0.159,
respectively).
The serological examination for the other pathogens revealed
that in F1, at 26 weeks of age, 8/15 pigs were seropositive for the
H3N2 subtype of SIV, 15/15 pigs were seropositive for PRRS(V)
and that 15/15 and 6/15 pigs were tested PCV-2 IgG and PCV-2
IgM positive, respectively. In F2, 0/15 pigs were seropositive for
the H3N2 subtype of SIV, 15/15 pigs were seropositive for PRRS
(V), while 15/15 and 10/15 pigs were tested PCV-2 IgG and
PCV-2 IgM positive, respectively.
Detection of M hyopneumoniae using qPCR on TBS
Group V1 had signiﬁcantly lower numbers of positive animals
compared with groups V2 and NV at 10 and 14 (both fattening
units) weeks of age (P=0.000 and P=0.041, respectively,
Table 7). The average qPCR values of M hyopneumoniae organ-
isms were lower in group V1 than in groups V2 and NV, across
TABLE 3: Performance parameters between 2 and 27 weeks (w) of age and percentage of market pigs in the three groups with
Mycoplasma hyopneumoniae-like lesions (Mhyo), fissures and pleurisy, and severity of lung lesions expressed as lung lesion score
(average±sd). Average values (±sd) are presented for each fattening unit (F1 and F2) separately. Minimum and maximum (min–
max) values of the lung lesion score are also presented
(F1) (F2)
Age (w) V1 V2 NV P value V1 V2 NV P value
Performance parameters* n=101 n=102 n=103 n=169 n=164 n=168
Average bodyweight (kg) 27 98.43±11.20 100.10±14.05 98.20±13.16 0.152 111.03±11.70 108.13±13.00 108.17±15.16 0.065
Weight gain (kg) 10–27 76.12±9.30 77.15±12.48 75.25±11.64 0.124 86.80±10.74A 83.96±11.69B 83.25±13.60B 0.011
2–27 94.33±10.98 95.91±13.90 93.99±12.94 0.124 106.68±11.55A 103.81±12.73B 103.65±14.92B 0.038
ADG (g/pig/day) 10–27 656±81 665±109 648±100 0.124 748±92A 722±101B 712±117B 0.010
2–27 562±65 570±82 559±77 0.139 634±68A 617±76B 616±88B 0.034
Lung lesions n=39 n=37 n=39 n=95 n=91 n=90
Prevalence of Mhyo-like lesions Market 32.4 41.0 48.7 0.357 36.1 36.9 37.6 0.980
Prevalence of fissures Market 51.3 43.6 48.7 0.788 31.3 36.9 35.0 0.727
Prevalence of pleurisy Market 7.5 14.6 15.0 0.529 7.0 7.6 11.2 0.579
Lung lesion score Market 3.68±7.57 4.88±11.79 3.56±5.93 0.628 3.33±6.43 4.50±10.88 5.04±11.51 0.844
Lung lesion score (min–max) Market 0–32 0–64 0–21 0–27 0–60 0–66
Treatment groups: V1 (vaccinated before weaning at 18 days of age), V2 (vaccinated on the day of weaning at 21 days of age) and NV (nonvaccinated group). Within a row,
different superscript letters indicate significant differences between values (P<0.05).
*Average daily gain (ADG).
TABLE 2: Performance parameters from 2 to 27 weeks (w) of age and percentage of market pigs in the three groups with
Mycoplasma hyopneumoniae-like lesions (Mhyo), fissures and pleurisy, and severity of lung lesions expressed as lung lesion score
(average±sd). Average values (±sd) were calculated taking into account both fattening units (F1 and F2). Minimum and maximum
(min–max) values of the lung lesion score are also presented
Age (w) V1 V2 NV P value
Performance parameters* n=270 n=266 n=271
Average bodyweight (kg) 2 4.28±0.78 4.32±0.77 4.31±0.76 0.919
10 23.56±3.76 23.99±3.71 24.28±3.90 0.109
27 106.81±12.96 105.21±13.88 104.12±15.17 0.263
Weight gain (kg) 10–27 83.26±11.44 81.46±12.41 80.10±13.42 0.094
2–27 102.55±12.76 100.95±13.68 99.71±14.90 0.164
ADG (g/pig/day) 2–10 371±64 376±69 384±67 0.076
10–27 718±98 701±108 688±116 0.094
2–27 610±76 600±81 593±88 0.164
Lung lesions n=134 n=128 n=129
Prevalence of Mhyo-like lesions Market 35.0 38.0 41.4 0.602
Prevalence of fissures Market 37.5 38.7 39.7 0.943
Prevalence of pleurisy Market 7.2 9.6 12.5 0.381
Lung lesion score Market 3.44±6.77 4.61±11.11 4.55±9.99 0.617
Lung lesion score (min–max) Market 0–32 0–64 0–66
Treatment groups: V1 (vaccinated before weaning at 18 days of age), V2 (vaccinated on the day of weaning at 21 days of age) and NV (non-vaccinated group). Differences
between groups were not statistically significant (P>0.05)
*Average daily weight gain (ADG)
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all sampling points, apart from F1 at 18 weeks of age where
group V1 had the second lowest qPCR value (2.03) when com-
pared with groups V2 (1.78) and NV (2.28). Signiﬁcant differ-
ences between groups were observed at 10, 14 and 18 (both
fattening units) weeks of age (P=0.000, P=0.000 and P=0.039,
respectively) (Table 7).
Lung lesions
Lung lesion evaluation at slaughter was performed on 391 pigs
(n=134 V1; n=128 V2; n=129 NV). Some pigs could not be
evaluated because of lost ear tags and lungs that did not reach
the examination stand. Taking into account both F1 and F2
(Table 2), no statistically signiﬁcant differences were found
between treatment groups across all measured parameters.
Discussion
The present ﬁeld study investigated the efﬁcacy of one-dose vac-
cination against M hyopneumoniae, applied either three days before
weaning (V1) or at the day of weaning (V2). The working
hypothesis was that group V1 will perform better than group V2
across the different parameters investigated as the possible
TABLE 4: The average (±sd) respiratory disease score (RDS) of
the pigs between 10 and 20 weeks of age and between 20
and 26 weeks (w) of age. Average values (±sd) were
calculated taking into account both and each fattening unit
(F1 and F2) separately
Age range (w) V1 V2 NV P value
Average both units n=270 n=266 n=271
10–20 1.76±1.90A 1.55±1.94A 1.77±1.78A 0.989
20–26 2.70±2.91A 3.68±2.86B 3.94±3.81B 0.801
P* 0.194 0.007 0.031
(F1) n=101 n=102 n=103
10–20 2.22±1.98 2.58±2.25 2.25±1.40 0.937
20–26 5.45±2.70 5.43±2.65 4.08±2.99 0.633
(F2) n=169 n=164 n=168
10–20 1.55±1.91 1.03±1.63 1.55±1.94 0.725
20–26 1.43±2.05 2.80±2.64 3.87±4.25 0.256
Treatment groups: V1 (vaccinated before weaning at 18 days of age), V2
(vaccinated on the day of weaning at 21 days of age) and NV (non-vaccinated
group). Within a column, different superscript letters correspond to within-group
significant differences between the two fattening periods (*P<0.05) (paired
t-tests). The P value column indicates that there were no significant differences
between groups during the two different fattening periods (P>0.05)
TABLE 5: Number of dead pigs per group between 2 and
27 weeks (w) of age. The contribution of each fattening unit
(F1 and F2) on the combined (both units) mortality rates
between 10 and 27 weeks of age is presented separately. All
mortality rates were calculated according to the total number
of animals included in each treatment group at the beginning
of the study (n=276)
Age range (w) V1 V2 NV P value
2–10 6/276 (2.17) 10/276 (3.62) 5/276 (1.81) 0.371
10–27 (both units) 9/276 (3.26) 10/276 (3.62) 15/276 (5.43) 0.260
2–27 15/276 (5.43) 20/276 (7.24) 20/276 (7.24) 0.607
(F1)
10–27 3/276 (1.09) 5/276 (1.81) 10/276 (3.62) 0.150
(F2)
10–27 6/276 (2.17) 5/276 (1.81) 5/276 (1.81) 0.983
Treatment groups: V1 (vaccinated before weaning at 18 days of age), V2
(vaccinated on the day of weaning at 21 days of age) and NV (non-vaccinated
group). The P value column indicates that there were no significant differences
between groups in mortality rates during the three different production periods
(P>0.05)
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FIG. 1: Average respiratory disease score (RDS) over time in each of three groups of pigs per fattening unit (F1 and F2). Average RDS, together
with the standard deviations (vertical bars), from 10 weeks of age until 26 weeks of age in group V1 (vaccinated before weaning at 18 days of
age), V2 (vaccinated on the day of weaning at 21 days of age) and NV (non-vaccinated group).
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negative effect of weaning stress on vaccination would be
decreased. Differences between group V1 and groups V2 and NV
were mostly not statistically signiﬁcant, except for the second fat-
tening unit (F2) where group V1 had signiﬁcantly higher weight
gains and ADG when compared with groups V2 and NV between
10 and 27 weeks of age, as well as the whole study period. When
taking into account both fattening units, group V1 had a numer-
ically lower percentage of pigs with pneumonia, ﬁssures and
pleurisy at slaughter when compared with groups V2 and NV.
The results of this study are in agreement with the previous
experimental study of Arsenakis and others (2016) where group
V1 performed better than V2 across all parameters concerning the
assessment of lung lesions; however, differences between V1 and
V2 were small and mostly statistically not signiﬁcant.
In the present ﬁeld study, serology and qPCR were both used
to conﬁrm the presence of pigs naturally infected with M hyop-
neumoniae. At 26 weeks of age (1 week before slaughter), the per-
centage of tested pigs being seropositive for M hyopneumoniae
ranged between 70 and 90 per cent, while at 18 weeks of age,
between 10 and 60 per cent of tested pigs were found to be
qPCR positive. These results indicate that M hyopneumoniae has
been involved as an important respiratory pathogen in both fat-
tening units. Martínez and others (2009) studied the relationship
between infectious factors and pneumonia at slaughter on 39
fattening herds and conﬁrmed that vaccination of piglets against
M hyopneumoniae did not appear to be related to the seropreva-
lences against the pathogen at slaughter. The qPCR results
indicate that infection with M hyopneumoniae started already
during the nursery period, which may explain the high preva-
lence of pulmonary ﬁssures at slaughter. Nevertheless, the diag-
nostic results show that apart from M hyopneumoniae, there
was a combination of viruses and other bacteria circulating in
this herd.
In this study, it was decided to use the scoring system of
Morrison and others (1985a), in order to quantify the severity of
macroscopically visibleMycoplasma-like lung lesions. Those lesions
are typically compatible with CBPn, which is the most common
lung lesion associated with M hyopneumoniae infection (Sorensen
and others 2006, Meyns and others 2011). It is characterised by
well-demarcated red-purplish areas that have a poor retraction
state and thus, this scoring system was considered to be able to
achieve the maximum possible differentiation against other types
of lung lesions that are usually induced by viral pathogens, namely
PRRS(V), SIVand PCV-2. Those pathogens most often cause inter-
stitial pneumonia (IPn; Van Alstine 2012). The main difference
between CBPn and IPn is that in the latter one, the lesions are
widely distributed throughout the lungs and the lung lobes main-
tain their rubbery consistency (Van Alstine 2012, López and
Martinson 2017). It is documented that M hyopneumoniae predis-
poses to secondary pathogens such as T pyogenes, P multocida and
S suis (Goodwin and others 1965, Morrison and others 1985b,
Ciprián and others 1988, Amass and others 1994, Opriessnig and
others 2011, López and Martinson 2017). By that way, the lung
lesions produced by M hyopneumoniae are exacerbated, leading to
TABLE 6: Ratios of seropositive/total number of pigs sampled per group at different time points as tested with the IDEIA,
M hyopneumoniae EIA Kit (Oxoid) are presented together with the inhibition percentages (IP). The contribution of each fattening
unit (F1 and F2) on the combined (both units) seropositivity ratios and IP at 18 and 26 weeks of age is presented separately
Seropositive pigs for M. hyopneumoniae/
total number of pigs sampled Average IP values
Age (w) V1 V2 NV P value V1 V2 NV P value
2 7/20 10/20 9/20 0.624 44.2 42.6 45.6 0.929
10 3/20 0/20 0/20 1.000 49.9A 43.4AB 35.9B 0.004
18 (both units) 5/20 4/20 3/20 0.735 39.0 47.4 29.3 0.066
26 (both units) 18/20 16/20 16/20 0.630 82.6 72.3 68.1 0.159
(F1)
18 2/10 2/10 0/10 0.980 33.4AB 39.1B 14.3A 0.011
26 9/10 9/10 7/10 0.246 84.3A 77.1B 52.4B 0.006
(F2)
18 3/10 2/10 3/10 0.863 44.6 55.7 44.2 0.682
26 9/10 7/10 9/10 0.421 81.0 67.6 83.8 0.358
Treatment groups: V1 (vaccinated before weaning at 18 days of age), V2 (vaccinated on the day of weaning at 21 days of age) and NV (nonvaccinated group). Within a row,
different superscript letters correspond to significant differences in the average IP values between groups during the different sampling points (P<0.05).
TABLE 7: Ratios of qPCR positive animals for Mycoplasma hyopneumoniae (Mhyo)/total number of pigs sampled per group at
different time points are presented together with the Log Mhyo copies/ml. The contribution of each fattening unit (F1 and F2) on
the combined (both units) qPCR positivity ratios and Log Mhyo copies/ml at 14 and 18 weeks of age is presented separately
qPCR positive pigs for M. hyopneumoniae /
total number of pigs sampled Log Mhyo copies/ml
Age (w) V1 V2 NV P value V1 V2 NV P value
10 0/20A 3/20B 17/20BC 0.000 0.58±0.71A 0.96±0.75AB 1.12±0.77C 0.000
14 (both units) 2/20A 7/20B 10/20BC 0.041 0.85±0.72A 1.21±1.20BC 1.76±1.59C 0.000
18 (both units) 2/20 8/20 8/20 0.088 1.99±2.45AB 2.21±2.44AC 2.19±2.35A 0.039
(F1)
14 2/10 2/10 7/10 0.073 0.91±0.25 1.05±1.21 1.62±1.38 0.257
18 1/10 6/10 4/10 0.183 2.03±2.50 1.78±2.03 2.28±2.32 0.076
(F2)
14 0/10 5/10 3/10 0.613 0.78±1.18A 1.33±1.17AB 1.86±1.69B 0.001
18 1/10 2/10 4/10 0.205 1.96±2.42 2.42±2.84 2.07±2.37 0.118
Treatment groups: V1 (vaccinated before weaning at 18 days of age), V2 (vaccinated on the day of weaning at 21 days of age) and NV (non-vaccinated group). Within a row,
different superscript letters indicate significant differences in the percentage of qPCR positive animals and qPCR values between groups during the different sampling points
(P<0.05).
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more severe CBPn and pleural adhesions which extend the healing
period (formation of ﬁssures). Additionally, M hyopneumoniae
together with the aforementioned pathogens form the patho-
logical complex of EP (Maes and others 1996, Thacker and Minion
2012). Vaccination against M hyopneumoniae in herds facing severe
EP has been shown to reduce the extent and severity of
Mycoplasma-like lung lesions (Maes and others 1999, Alexopoulos
and others 2004, Del Pozo Sacristán and others 2014).
In the current study, the percentage of pigs being positive for
M hyopneumoniae by qPCR increased between 14 and 18 weeks
of age and the percentage of pigs seropositive for M hyopneumo-
niae increased between 18 and 26 weeks of age. Additionally, in
both F1 and F2, the RDS increased between 20 and 26 weeks of
age when compared with the period between 10 and 20 weeks of
age. This increase in the RDS occurred almost simultaneously
with the increase in the percentage of M hyopneumoniae seroposi-
tive animals towards the end of the fattening period. Nathues
and others (2012), who examined the value of clinical examin-
ation in diagnosing EP in fattening pigs from 59 herds at
18 weeks of age, suggested that a combination of an increasing
RDS towards the end of the fattening period together with a
seroprevalence of more than 50 per cent againstM hyopneumoniae
is highly indicative of an EP diagnosis. In the current study, the
EP diagnosis is also justiﬁed by the detection of secondary patho-
gens, such as T pyogenes, P multocida and S suis, in the pigs that
underwent postmortem examination during the fattening
period. The average percentage of Mycoplasma-like pneumonia
lesions, in both F1 and F2, was considerably higher (38 per cent)
than the average of 24 per cent reported by Meyns and others
(2011), who collected data from 50 randomly selected batches
from 60 Belgian herds at slaughter.
Of course, it is important to mention that viral pathogens,
such as PRRS(V), SIV and PCV-2, were present in both fattening
units (as documented by the diagnostics performed). The pres-
ence of such coinfections conﬁrms the multifactorial nature of
porcine respiratory disease complex (PRDC) in the present herd
and could probably explain why in most of the measured para-
meters the vaccinated groups V1 and V2 did not perform signiﬁ-
cantly better than the NV group. The high percentage of
Mycoplasma-like pneumonia lesions among all groups can likely
be the result of interactions between M hyopneumoniae and the
viral (PRRS(V), SIV and PCV-2)) pathogens observed. All tested
pigs were seropositive for PRRS(V) and PCV-2 IgG at 20, 23 and
26 weeks of age, and additionally a high number of pigs were
seropositive for PCV-2 IgM at 26 weeks of age. Given that all
pigs participating in this trial did not receive any other vaccin-
ation apart from the one with the commercial M hyopneumoniae
bacterin, these results prove that the herd was facing a chronic
PRRS(V) infection in combination with a circulating PCV-2
infection at the nursery and fattening units.
It is generally acknowledged that most PRRS(V) and PCV-2
infections occurring at the end of the fattening period are sub-
clinical and thus, this is the reason why in many cases no gross
IPn lesions are detected at slaughter (Segalés and others 2012,
Pileri and Mateu 2016). Nevertheless, the potentiating effect of
the combination of viral pathogens with a M hyopneumoniae
infection on the severity of Mycoplasma-like lung lesions induced
has already been experimentally described by Thacker and others
(1999, 2001), Opriessnig and others (2004) and Dorr and others
(2007), and demonstrated under ﬁeld conditions by Del Pozo
Sacristán and others (2014). It is possible that in this study a
better control of viral pathogens such as PRRS(V), PCV-2 and
SIV through better biosecurity and vaccination at an early age
would allow vaccination against M hyopneumoniae to demon-
strate signiﬁcant beneﬁts versus the NV animals in terms of the
severity of Mycoplasma-like lung lesions induced. Previously pub-
lished studies performed in herds facing mixed infections with
the above-mentioned pathogens showed that vaccination against
PCV-2 (Raith and others 2015, Duivon and others 2016) and
PRRS(V) (Revilla and others 2006), in combination with vaccin-
ation against M hyopneumoniae, further reduced the prevalence of
Mycoplasma-like lung lesions at slaughter (Raith and others
2015, Duivon and others 2016), reduced mortality rates (Revilla
and others 2006) and increased the ADG during the fattening
period (Duivon and others 2016), when compared with M hyop-
neumoniae vaccination alone.
The possible effect of other vaccinations applied during the
same time period on M hyopneumoniae vaccination or vice versa
is not known. Experimental studies showed that a modiﬁed live
PRRS(V) vaccine based on a US-type PRRS(V) strain (Thacker
and others 2000) applied in the same time period as M hyopneu-
moniae vaccination decreased the efﬁcacy of M hyopneumoniae
vaccination. In contrast, this did not occur when a PRRS(V)
vaccine based on an EU-type PRRS(V) strain was used (Drexler
and others 2010). However, it is not known whether a possible
interaction of M hyopneumoniae vaccination and other vaccines
applied at the same time period would be different when applied
at weaning or shortly before weaning.
The evolution of respiratory distress in F1 is more typical of
a SIV outbreak as a clear increase in the RDS was observed at
20 weeks of age and lasted for almost a week. A similar increase
in coughing severity during a SIV outbreak has already been
described by Berckmans and others (2015) after using micro-
phones for monitoring respiratory distress in a Dutch herd over a
three-month period. For the remaining fattening period of up to
26 weeks of age, a signiﬁcantly higher overall average RDS was
observed in F1 compared with F2. Thacker and others (2001)
reported that concurrent infection with M hyopneumoniae and
SIV increased the severity and duration of EP. Van Reeth and
others (1996) found that the clinical effects of PRRS(V) were
exacerbated with concurrent infection with SIV. Also, it is well
established that secondary infections with bacteria such as P
multocida and S suis may enhance the severity of a SIV outbreak
(Van Reeth and others 2012). Considering all the above and also
the fact that there are many between-pathogen interactions
which have not yet been fully elucidated, the higher RDS
observed in F1 compared with F2 as well as the inconsistency in
the results of group V1 for some of the measured parameters
(such as the weight gains and ADG across the different fattening
units) could possibly be attributed to the SIV outbreak. The
proximity of F1 to the sow herd and the nursery unit provides a
possible explanation for the origin of the SIVoutbreak.
At 10 and 14 weeks of age, group V1 had signiﬁcantly less
animals being qPCR positive for M hyopneumoniae than groups
V2 and NV. Nevertheless, the impact of this lower colonisation
rate on the performance and clinical parameters remains unclear.
A limitation of the current study is that this lower colonisation
rate together with the signiﬁcantly lower average qPCR values
(Log M hyopneumoniae copies/ml) detected in group V1 com-
pared with groups V2 and NV could neither be conﬁrmed before
slaughter, since there were no TBS obtained at 26 or 27 weeks of
age. In a ﬁeld study of Sibila and others (2007), which compared
two different M hyopneumoniae vaccination programmes (two
vaccine doses at 1 and 3 weeks of age versus one dose at 6 weeks
of age) with a control group, vaccination was related to a reduc-
tion in the number of animals found to be nPCR positive at
25 weeks of age (37.5 per cent and 55.8 per cent of the vacci-
nated animals, respectively, and 70.2 per cent of the control
group). However, no quantitative method such as qPCR was
used. It was concluded that a qPCR would be more useful in elu-
cidating whether vaccination reduces the bacterial load in the
upper respiratory airways during the late stages of the fattening
period. Possibly, the reduced bacterial load could be associated
with the shedding of less organisms. This could be interesting to
investigate in a future experimental trial, where vaccinated and
NV fattening pigs would be purchased from a farrow-to-ﬁnish
herd and then involved in a transmission experiment using direct
nose-to-nose contact.
Although this study included a high number of animals, the
results should be interpreted with caution, particularly when
trying to draw general conclusions from a single study. It should
always be taken into account that biosecurity levels, climatic
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environment and management conditions as well as metaphylac-
tic antimicrobial treatment and vaccination programmes differ
between herds facing concurrent infections withM hyopneumoniae
and other respiratory pathogens. The above-mentioned para-
meters inﬂuence not only mixed respiratory tract infection
dynamics (Bochev 2007, 2008, Thacker and Minion 2012), but
also the efﬁcacy of the vaccination protocols applied against
M hyopneumoniae (Maes and others 2008). Therefore, more herds
with mixed respiratory disease where M hyopneumoniae is involved
as an important pathogen need to be investigated, in order to
discover the most suitable techniques for making vaccination
protocols that are tailored to the individual needs of each herd.
In conclusion, the fact that in F2 group V1 had signiﬁcantly
higher weight gains and ADG compared with groups V2 and NV
is indicative of the potential beneﬁts of vaccinating against
M hyopneumoniae three days before weaning. The SIVoutbreak in
F1 and the presence of other respiratory pathogens in both F1
and F2 likely inﬂuenced the performance of both vaccinated
groups and highlight the difﬁculties of evaluating interventions
in ﬁeld settings. Thus, additional studies are necessary to further
explore the possible impact of the process of weaning on the
efﬁcacy of vaccination against M hyopneumoniae.
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